vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Trimble Inc. (TRMB). Click either name above to swap in a different company.

Trimble Inc. is the larger business by last-quarter revenue ($969.8M vs $487.7M, roughly 2.0× CLOVER HEALTH INVESTMENTS, CORP.). Trimble Inc. runs the higher net margin — 16.1% vs -10.1%, a 26.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -73.7%). Trimble Inc. produced more free cash flow last quarter ($360.9M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 0.9%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Trimble Inc. is an American software, hardware, and services technology company that was founded in 1978. Its headquarters is in Westminster, Colorado. It is publicly traded on the Nasdaq and listed on the S&P 500. Trimble develops hardware and software for a variety of business sectors including architecture, engineering, and construction (AEC); surveying, mapping, and geomatics (geospatial); and transportation and logistics (T&L).

CLOV vs TRMB — Head-to-Head

Bigger by revenue
TRMB
TRMB
2.0× larger
TRMB
$969.8M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+118.4% gap
CLOV
44.7%
-73.7%
TRMB
Higher net margin
TRMB
TRMB
26.3% more per $
TRMB
16.1%
-10.1%
CLOV
More free cash flow
TRMB
TRMB
$429.9M more FCF
TRMB
$360.9M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
0.9%
TRMB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
TRMB
TRMB
Revenue
$487.7M
$969.8M
Net Profit
$-49.3M
$156.6M
Gross Margin
72.0%
Operating Margin
-10.1%
22.3%
Net Margin
-10.1%
16.1%
Revenue YoY
44.7%
-73.7%
Net Profit YoY
-123.2%
73.6%
EPS (diluted)
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TRMB
TRMB
Q4 25
$487.7M
$901.2M
Q3 25
$496.6M
$875.7M
Q2 25
$477.6M
$840.6M
Q1 25
$462.3M
$983.4M
Q4 24
$337.0M
Q3 24
$331.0M
$875.8M
Q2 24
$356.3M
$870.8M
Q1 24
$346.9M
$953.3M
Net Profit
CLOV
CLOV
TRMB
TRMB
Q4 25
$-49.3M
$111.5M
Q3 25
$-24.4M
$89.2M
Q2 25
$-10.6M
$66.7M
Q1 25
$-1.3M
$90.2M
Q4 24
$-22.1M
Q3 24
$-9.2M
$40.6M
Q2 24
$7.4M
$1.3B
Q1 24
$-19.2M
$57.2M
Gross Margin
CLOV
CLOV
TRMB
TRMB
Q4 25
68.9%
Q3 25
68.3%
Q2 25
66.7%
Q1 25
69.3%
Q4 24
Q3 24
24.5%
65.7%
Q2 24
30.3%
62.7%
Q1 24
23.6%
62.3%
Operating Margin
CLOV
CLOV
TRMB
TRMB
Q4 25
-10.1%
16.7%
Q3 25
-4.9%
14.6%
Q2 25
-2.2%
11.6%
Q1 25
-0.3%
17.6%
Q4 24
-6.4%
Q3 24
-2.7%
13.3%
Q2 24
2.0%
7.1%
Q1 24
-6.5%
11.5%
Net Margin
CLOV
CLOV
TRMB
TRMB
Q4 25
-10.1%
12.4%
Q3 25
-4.9%
10.2%
Q2 25
-2.2%
7.9%
Q1 25
-0.3%
9.2%
Q4 24
-6.6%
Q3 24
-2.8%
4.6%
Q2 24
2.1%
151.2%
Q1 24
-5.5%
6.0%
EPS (diluted)
CLOV
CLOV
TRMB
TRMB
Q4 25
$0.46
Q3 25
$0.37
Q2 25
$0.27
Q1 25
$0.36
Q4 24
Q3 24
$0.16
Q2 24
$5.34
Q1 24
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TRMB
TRMB
Cash + ST InvestmentsLiquidity on hand
$78.3M
$253.4M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$308.7M
$5.8B
Total Assets
$541.0M
$9.3B
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TRMB
TRMB
Q4 25
$78.3M
$232.7M
Q3 25
$265.9M
Q2 25
$290.0M
Q1 25
$738.8M
Q4 24
$194.5M
Q3 24
$288.0M
$1.0B
Q2 24
$254.8M
$944.1M
Q1 24
$208.3M
$255.1M
Total Debt
CLOV
CLOV
TRMB
TRMB
Q4 25
$1.4B
Q3 25
Q2 25
Q1 25
$1.4B
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
TRMB
TRMB
Q4 25
$308.7M
$5.8B
Q3 25
$340.9M
$5.7B
Q2 25
$344.2M
$5.4B
Q1 25
$336.1M
$5.7B
Q4 24
$341.1M
Q3 24
$342.2M
$5.9B
Q2 24
$324.9M
$5.6B
Q1 24
$292.5M
$4.3B
Total Assets
CLOV
CLOV
TRMB
TRMB
Q4 25
$541.0M
$9.0B
Q3 25
$559.7M
$9.1B
Q2 25
$575.0M
$8.9B
Q1 25
$583.7M
$9.5B
Q4 24
$580.7M
Q3 24
$653.0M
$9.9B
Q2 24
$674.2M
$9.6B
Q1 24
$671.8M
$9.3B
Debt / Equity
CLOV
CLOV
TRMB
TRMB
Q4 25
0.24×
Q3 25
Q2 25
Q1 25
0.24×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TRMB
TRMB
Operating Cash FlowLast quarter
$-66.9M
$386.2M
Free Cash FlowOCF − Capex
$-69.0M
$360.9M
FCF MarginFCF / Revenue
-14.1%
37.2%
Capex IntensityCapex / Revenue
0.4%
2.6%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TRMB
TRMB
Q4 25
$-66.9M
Q3 25
$12.1M
$123.8M
Q2 25
$5.4M
$155.6M
Q1 25
$-16.3M
$115.1M
Q4 24
$34.8M
Q3 24
$50.0M
$94.9M
Q2 24
$44.8M
$87.6M
Q1 24
$25.9M
$233.8M
Free Cash Flow
CLOV
CLOV
TRMB
TRMB
Q4 25
$-69.0M
Q3 25
$11.4M
$116.6M
Q2 25
$4.8M
$149.0M
Q1 25
$-16.5M
$109.0M
Q4 24
$33.3M
Q3 24
$49.6M
$88.5M
Q2 24
$44.4M
$73.3M
Q1 24
$25.5M
$227.0M
FCF Margin
CLOV
CLOV
TRMB
TRMB
Q4 25
-14.1%
Q3 25
2.3%
13.3%
Q2 25
1.0%
17.7%
Q1 25
-3.6%
11.1%
Q4 24
9.9%
Q3 24
15.0%
10.1%
Q2 24
12.5%
8.4%
Q1 24
7.3%
23.8%
Capex Intensity
CLOV
CLOV
TRMB
TRMB
Q4 25
0.4%
Q3 25
0.1%
0.8%
Q2 25
0.1%
0.8%
Q1 25
0.0%
0.6%
Q4 24
0.5%
Q3 24
0.1%
0.7%
Q2 24
0.1%
1.6%
Q1 24
0.1%
0.7%
Cash Conversion
CLOV
CLOV
TRMB
TRMB
Q4 25
Q3 25
1.39×
Q2 25
2.33×
Q1 25
1.28×
Q4 24
Q3 24
2.34×
Q2 24
6.04×
0.07×
Q1 24
4.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TRMB
TRMB

Subscription and services$701.5M72%
Product$268.3M28%

Related Comparisons